Synflorix

Type: Keyphrase
Name: Synflorix
First reported Sep 11 2014 - Updated Sep 12 2014 - 3 reports

Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020

DUBLIN, Ireland, September 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/fqhgtd/pipeline_analysis) has announced the addition of the "Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid ... [Published PR Newswire: General Business - Sep 12 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 4 reports

Research and Markets: Pipeline Analysis of Hospital Acquired Pneumonia Drugs 2014-2020: Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix

Research and Markets ( http://www.researchandmarkets.com/research/p4k6zl/pipeline_analysis ) has announced the addition of the "Pipeline Analysis of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... [Published Fort Mills Times - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Six hospital-acquired pneumonia drugs in late-stage development could generate $3.8bn by 2020

Six drugs currently in Phase III studies to treat hospital-acquired pneumonia would generate total revenue of $3.8 billion by 2020, according to a new report from Transparency Market Research.Hospital-acquired infections have raised serious concerns due ... [Published Pharma Letter - Sep 09 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

GSK to improve access to vaccines

GlaxoSmithKline (GSK) has announced that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support. By committing to offer GAVI Alliance prices for vaccines against pneumonia, diarrhoea ... [Published Spy Ghana - Aug 26 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Half Yearly Report

Total Group turnover for Q2 2014 declined 4% to £5,561 million. Pharmaceuticals and Vaccines turnover fell by 4%. Pharmaceuticals turnover declined 6% as growth in Emerging Markets, Europe and ViiV Healthcare was more than offset by lower sales in the ... [Published TrustNet - Jul 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Nigeria, India out of purview

Mumbai, April 22: GlaxosmithKline Plc has deliberately left India and Nigeria out of the ambit of the new global joint venture that GSK and Novartis are forming for their consumer healthcare business. It chose to do so because they were the only two countries ... [Published Calcutta Telegraph - Apr 23 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

GSK sales impacted with new price control regime & boycott of stockists

The new price control regime and boycott of stockists coupled with supply constraints domestically and overseas have badly impacted the GlaxoSmithKline (GSK) results towards the end of the third quarter and bulk of the fourth quarter.  Profits were impacted ... [Published PharmaBiz - Apr 19 2014]

Quotes

Research and Markets (http://www.researchandmarkets.com/research/fqhgtd/pipeline_analysis) has announced the addition of the  "Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate,..."
Research and Markets ( http://www.researchandmarkets.com/research/p4k6zl/pipeline_analysis ) has announced the addition of the "Pipeline Analysis of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014…"
Says Hasit Joshipura, managing director, GSK, "Besides this, the mass specialty business recorded a market competitive growth in the prescriber base which has resulted in benefits to patients with Augmentin, an antibiotic used to treat bacterial infections, such as sinusitis, pneumonia and bronchitis gaining significantly in market share. To address health concerns in hypothyroidism, two additional forms of Eltroxin have also been launched coupled with an awareness campaign on congenital hypothyroidism."

More Content

All (16) | News (10) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Global Pipeline Analysis of Hospital Acquired P... [Published PR Newswire: General Business - Sep 12 2014]
Global Pipeline Analysis of Hospital Acquired P... [Published PR Newswire: General Business - Sep 12 2014]
Pipeline Analysis of Hospital Acquired Pneumoni... [Published PR Newswire: Entertainment & Media - Sep 11 2014]
Research and Markets: Pipeline Analysis of Hosp... [Published Fort Mills Times - Sep 10 2014]
Research and Markets: Pipeline Analysis of Hosp... [Published Digital Journal - Sep 10 2014]
Research and Markets: Pipeline Analysis of Hosp... [Published Business Wire Health News - Sep 10 2014]
Pipeline Analysis of Hospital Acquired Pneumoni... [Published Individual.com - Sep 10 2014]
Six hospital-acquired pneumonia drugs in late-s... [Published Pharma Letter - Sep 09 2014]
GSK to improve access to vaccines [Published Spy Ghana - Aug 26 2014]
Half Yearly Report [Published TrustNet - Jul 23 2014]
Nigeria, India out of purview [Published Calcutta Telegraph - Apr 23 2014]
GSK sales impacted with new price control regim... [Published PharmaBiz - Apr 19 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Feb 18 2014]
Final Results [Published TrustNet - Feb 05 2014]
GlaxoSmithKline Pte offers Rs.3,100 per share t... [Published PharmaBiz - Dec 16 2013]
Fact Sheet for GlaxoSmithKline Pharmaceuticals Ltd [Published Able2Act - May 06 2008]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Global Pipeline Analysis of Hospital Acquired P... [Published PR Newswire: General Business - Sep 12 2014]
DUBLIN, Ireland, September 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/fqhgtd/pipeline_analysis) has announced the addition of the "Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid ...
Global Pipeline Analysis of Hospital Acquired P... [Published PR Newswire: General Business - Sep 12 2014]
DUBLIN, September 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/fqhgtd/pipeline_analysis) has announced the addition of the "Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, ...
Pipeline Analysis of Hospital Acquired Pneumoni... [Published PR Newswire: Entertainment & Media - Sep 11 2014]
NEW YORK, Sept. 11, 2014 /PRNewswire/ -- Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused ...
Research and Markets: Pipeline Analysis of Hosp... [Published Business Wire Health News - Sep 10 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p4k6zl/pipeline_analysis) has announced the addition of the "Pipeline Analysis of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Feb 18 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.